Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/79451
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorForeman, A.en
dc.contributor.authorJervis-Bardy, J.en
dc.contributor.authorBoase, S.en
dc.contributor.authorTan, L.en
dc.contributor.authorWormald, P.en
dc.date.issued2013en
dc.identifier.citationInternational Forum of Allergy & Rhinology, 2013; 3(2):83-88en
dc.identifier.issn2042-6976en
dc.identifier.issn2042-6984en
dc.identifier.urihttp://hdl.handle.net/2440/79451-
dc.description.abstractBACKGROUND The role that bacterial biofilms might play in recalcitrant forms of chronic rhinosinusitis (CRS) is increasingly being recognized. However, the detection of bacteria existing in this form, using standard culture, is limited by their unique metabolically inactive properties. All current biofilm diagnostic modalities require invasive mucosal biopsies, which limit their use to the operating theatre. METHODS Twenty CRS patients and 5 controls were enrolled in a prospective study to assess the feasibility of noninvasively diagnosing S. aureus biofilms by detecting the biofilm matrix polysaccharide poly-N-acetylglucosamine (PNAG). An immunofluorescence protocol was developed for PNAG detection and compared with both standard microbiological cultures and fluorescence in situ hybridization (FISH). RESULTS Thirteen of 20 CRS patients had evidence of S. aureus biofilm formation using FISH. Of these, 12 had detectable PNAG. Interestingly none of the S. aureus FISH-negative patients were PNAG-positive despite the presence of coagulase-negative Staphylococci biofilms, some of which may exhibit PNAG in their pathogenic forms. The development of a noninvasive S. aureus biofilm diagnostic test provides a reliable means to identify a high-risk group of CRS patients who harbor S. aureus biofilms. The ability to be used outside of the perioperative period to assess surgical efficacy, guide management, and evaluate new treatment modalities provides a significant advance in this field of research and clinical practice. CONCLUSION This study has confirmed the feasibility of noninvasive detection of S. aureus biofilms with a simple test that produces results comparable to the more invasive methods that are currently relied upon.en
dc.description.statementofresponsibilityAndrew Foreman, Josh Jervis-Bardy, Samuel J. Boase, Lorwai Tan, and Peter-John Wormalden
dc.language.isoenen
dc.publisherAmerican Rhinologic Societyen
dc.rights© 2013 ARS-AAOA, LLCen
dc.subjectCRS; biofilm; S. aureus; PNAG; FISH; immunofluorescenceen
dc.titleNoninvasive Staphylococcus aureus biofilm determination in chronic rhinosinusitis by detecting the exopolysaccharide matrix component poly-N-acetylglucosamineen
dc.typeJournal articleen
dc.identifier.doi10.1002/alr.21115en
pubs.publication-statusPublisheden
dc.identifier.orcidWormald, P. [0000-0001-7753-7277]en
Appears in Collections:Surgery publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.